Brian G. Hartl
- Co-authors
- Alan J. KrakerAneesa M. AmarMark R. BarvianHollis D. ShowalterCharles Watson MooreH. D. Hollis ShowalterWilliam A. DennyRonald L. Merriman
- Topics
- HER2/EGFR in Cancer Research (2 papers)Protein Kinase Regulation and GTPase Signaling (2 papers)Fibroblast Growth Factor Research (2 papers)
- Journals
- Journal of Medicinal ChemistryBiochemical PharmacologyBioorganic & Medicinal Chemistry Letters
- Partner nations
- New ZealandUnited States
In The Last Decade
Brian G. Hartl
6 papers receiving 284 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 167
- Organic Chemistry 115
- Oncology 58
- Hematology 48
- Computational Theory and Mathematics 33
Countries citing papers authored by Brian G. Hartl
This map shows the geographic impact of Brian G. Hartl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian G. Hartl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian G. Hartl more than expected).
Fields of papers citing papers by Brian G. Hartl
This network shows the impact of papers produced by Brian G. Hartl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian G. Hartl. The network helps show where Brian G. Hartl may publish in the future.
Co-authorship network of co-authors of Brian G. Hartl
This figure shows the co-authorship network connecting the top 25 collaborators of Brian G. Hartl. A scholar is included among the top collaborators of Brian G. Hartl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian G. Hartl. Brian G. Hartl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma. | 55 |
| 2 | 121 | |
| 3 | 40 | |
| 4 | 30 | |
| 5 | 38 | |
| 6 | 11 |
About Brian G. Hartl
Brian G. Hartl is a scholar working on Oncology, Molecular Biology and Organic Chemistry, having authored 6 papers that have together received 295 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hematology (48 citations), Organic Chemistry (115 citations) and Toxicology (11 citations). Brian G. Hartl has collaborated with scholars based in New Zealand and United States. Frequent co-authors include Alan J. Kraker, Aneesa M. Amar, Mark R. Barvian, Hollis D. Showalter, Charles Watson Moore, H. D. Hollis Showalter, William A. Denny, Ronald L. Merriman, Craig A. Mizzen and C. David Allis. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.